ALLOCYTE® Plus Advanced
Viable Bone Matrix
ALLOCYTE® Plus Advanced Viable Bone Matrix is a next-
generation cellular bone allograft with viable, bone-derived
progenitor cells and DMSO-free cryoprotectant.
Distinguishing Features
Graft viability post thaw
4 Hours
Thaw in warm saline without decanting for
10 Minutes
Cell viability post-thaw is at least
92%
of initial viable and active cell count
Cells protected by proprietary cryoprotectant
ALLOCYTE® Plus Advanced
Viable Bone Matrix Proprietary
DMSO-free cryoprotectant
2.5% DMSO solution
Cytotoxicity assay showing higher number of viable cells in media containing up to 10% cryoprotectant (left) compared to media containing 2.5% DMSO (right), after 48 hours incubation period.
References
- 1. Data on file.
- 2. Data on file
Most Recent Press Releases
Sanara MedTech Inc. Announces Chief Executive Officer Transition
September 2, 2025Contact Sanara MedTech
"*" indicates required fields
